Last reviewed · How we verify
NCT05835635: CABO-LA
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
trial in Patient Satisfaction in 50 participants. Not yet recruiting.
1 December 2025
Quick facts
| Lead sponsor | Pontificia Universidad Catolica de Chile |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 May 2025 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 May 2026 |
| Sites | 1 location across Chile |
Conditions studied
- Patient Satisfaction — all drugs for Patient Satisfaction →
- Patient Preference — all drugs for Patient Preference →
- Quality of Life — all drugs for Quality of Life →
- Acceptability of Health Care — all drugs for Acceptability of Health Care →
Sponsor
Pontificia Universidad Catolica de Chile — full company profile →
Who can join
18 and older, any sex, with Patient Satisfaction or Patient Preference. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This protocol will assess the level of satisfaction, acceptance of treatment and quality of life of patients with undetectable HIV who voluntarily change from oral to injectable antiretroviral treatment at 72 weeks of follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05835635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patient Satisfaction
Currently open trials in the same condition.
- NCT07464080 — Advanced Brain Imaging-TKA (fMRI-TKA) · NA · recruiting
- NCT07311525 — Ultrasound-Guided RSCTL vs EOIP Block for Analgesia in Sleeve Gastrectomy · NA · recruiting
- NCT07517926 — Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms · NA · recruiting
- NCT06975033 — Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP · NA · recruiting
- NCT07274072 — Hospital at Home Versus Inpatient Care: Costs and Effectiveness · recruiting
Other Pontificia Universidad Catolica de Chile trials
Trials by the same sponsor.
- NCT07396129 — Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain · Phase 1, PHASE2 · not yet recruiting
- NCT07510425 — Artificial Intelligence vs. Automated Messaging for Continuous Regional Analgesia Follow-up · NA · not yet recruiting
- NCT07380451 — Modular Intervention for Depression Study · NA · not yet recruiting
- NCT07324499 — Effect of Dexamethasone on Plasma Levels of Bupivacaine and Dexamethasone After a Single-injection Interscalene Nerve Bl · NA · not yet recruiting
- NCT07330947 — Incidence and Risk Factors of Postoperative Chronic Pain in Patients Who Have Undergone Hallux Valgus Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05835635 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pontificia Universidad Catolica de Chile
- Last refreshed: 7 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05835635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing